SJS Investment Consulting’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
SJS Investment Consulting's AMRX Position: Q3 2026 in Review
SJS Investment Consulting held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 541 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.
SJS Investment Consulting first reported a position in AMRX in Q1 2022 and has held it in 9 quarters since. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- SJS Investment Consulting held 541 shares of Amneal Pharmaceuticals worth $10.9K as of Q3 2026.
- SJS Investment Consulting left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
- Amneal Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1296 holding.
- SJS Investment Consulting first reported a position in Amneal Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.